Our History

2021

JULY 2021

Laureate of i-Lab Innovation Competition

Panntherapi is laureate of the 2021 i-Lab Innovation Competition.

MARCH 2021

Panntherapi creation

The company was founded in March 2021 in France by a management team that has an extensive experience with biotech/ pharma companies and proven track-record in developing treatments for neurological and orphan diseases.

[bold_timeline_item_button title= »Expand » style= » » shape= » » color= » » size= »inline » url= »# » el_class= »bold_timeline_group_button »]

2020

DECEMBER 2020

Panntherapi incubation

Panntherapi is incubated since December 2020 at Paris Biotech Santé (Paris) and BIC Innov’Up (Nîmes)

[bold_timeline_item_button title= »Expand » style= » » shape= » » color= » » size= »inline » url= »# » el_class= »bold_timeline_group_button »]

2018

MARCH 2018

Work on pannexin

 PannTheraPi originates from PSL valorization of the work of Drs Nathalie Rouach, Elena Dossi and Gilles Huberfeld on pannexin channels using brain tissue from epileptic patients.

[bold_timeline_item_button title= »Expand » style= » » shape= » » color= » » size= »inline » url= »# » el_class= »bold_timeline_group_button »]

COMPANY HISTORYPanntherapi

Life-changing for patients suffering from Neurological Diseases

Panntherapi is a pharmaceutical company dedicated to the development of innovative drugs for the treatment of brain disorders, primarily epilepsy and then other indications such as multiple sclerosis, pain or migraine.